Perspective Therapeutics, Inc. — Director's Dealing 2025

Mar 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2025-03-03

Reporting Person: HENSON HEIDI (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-03	Stock option (right to buy)	$2.46	A	50000	Acquired	2035-03-03	Common Stock (50000)	Direct

Footnotes

F1: The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025, and represents the Reporting Person's annual equity award for 2025.

F2: Option vests in full on March 3, 2026, subject to the Reporting Person's continued service on the vesting date.